Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02584673 · ClinicalTrials.gov registry record · NA
Computer Assisted Instrument Guidance (CAIG) For Arterial Line Placement
A NA study, sponsored by Clear Guide Medical.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02584673: Completed NA study, sponsored by Clear Guide Medical.
NCT02584673 is a NA study that has completed, run by Clear Guide Medical. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02584673, a NA study, has completed, sponsored by Clear Guide Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The objective of this research is to verify the procedural improvements enabled by use of a CAIG system to supplement existing ultrasound guided, needle-based procedures. The primary focus will be procedures performed by the Anesthesia department.
Interventions
- DEVICE Computer Assisted Instrument Guidance (CAIG), which supplements existing ultrasound capabilities.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-10 |
| Est. Completion | 2016-12-09 |
| Phase | NA |
What the finished NCT02584673 record still lists
NCT02584673 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Computer Assisted Instrument Guidance (CAIG), which supplements existing ultrasound capabilities. is the first listed.
NCT02584673 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02584673 about?
NCT02584673 is a clinical study titled "Computer Assisted Instrument Guidance (CAIG) For Arterial Line Placement". The objective of this research is to verify the procedural improvements enabled by use of a CAIG system to supplement existing ultrasound guided, needle-based procedures. The primary focus will be procedures performed by the Anesthesia department.
What is the current status of trial NCT02584673?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2015-10. Estimated completion is 2016-12-09.
What interventions are being tested in trial NCT02584673?
The interventions under investigation include: Computer Assisted Instrument Guidance (CAIG), which supplements existing ultrasound capabilities. (DEVICE).
Who is sponsoring clinical trial NCT02584673?
This trial is sponsored by Clear Guide Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02584673's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia